Activated transport mechanism

Care should be exercised when attempting to interpret in vivo pharmacological data in terms of specific chemical—biological interactions for a series of asymmetric compounds, particularly when this interaction is the only parameter considered in the analysis (10). It is important to recognize that the observed difference in activity between optical antipodes is not simply a result of the association of the compound with an enzyme or receptor target. Enantiomers differ in absorption rates across membranes, especially where active transport mechanisms are involved (11). They bind with different affinities to plasma proteins (12) and undergo alternative metaboHc and detoxification processes (13). This ultimately leads to one enantiomer being more available to produce a therapeutic effect. 

Because bretylium is poody absorbed from the GI tract (- 10%), it is adrninistered iv or im. Very litde dmg is protein bound in plasma. Bretylium is taken up by an active transport mechanism into and concentrated in postganglionic nerve terminals of adrenergicahy innervated organs. Peak plasma concentrations after im injections occur in about 30 min. Therapeutic plasma concentrations are 0.5—1.0 p.g/mL. Bretylium is not metabolized and >90% of the dose is excreted by the kidneys as unchanged dmg. The plasma half-life is 4—17 h (1,2). 

Figure 24. Plot of the particle-size distribution versus the transition temperature Tross, which describes the crossover point between an activated transport mechanism (ln(A) oc EJT and variable range hopping (VRH) (ln(R)ocT ). Note that Tdoss has a OK value at a finite (3%) particle-size distribution. (Reprinted with permission from Ref. [56], 2002, American Chemical Society.)...

The study of active transport mechanisms has grown substantially in recent years, with transport proteins such as P-gp, BCRP, and MRP-2 among the most studied [59]. Several types of in vitro assays to assess substrates of transporters have been established these include assays directed toward intestinal and biliary efflux [60]. Assays that measure passive and active transport are also used to assess penetration of the blood-brain barrier. In addition to the assays described above, transfected cell lines that overexpress transporters present in the blood-brain barrier are also employed [61]. 

FIGURE 29-2. Levodopa absorption and metabolism. Levodopa is absorbed in the small intestine and is distributed into the plasma and brain compartments by an active transport mechanism. Levodopa is metabolized by dopa decarboxylase, monoamine oxidase, and catechol-O-methyltransferase. Carbidopa does not cross the blood-brain barrier. Large, neutral amino acids in food compete with levodopa for intestinal absorption (transport across gut endothelium to plasma). They also compete for transport across the brain (plasma compartment to brain compartment). Food and anticholinergics delay gastric emptying resulting in levodopa degradation in the stomach and a decreased amount of levodopa absorbed. If the interaction becomes a problem, administer levodopa 30 minutes before or 60 minutes after meals. 

Drugs absorbed by active transport mechanisms appear to have a delayed rate, but not extent of absorption, in the neonatal period [20]. The absorption of vitamin K depends, to some extent, on the development of intestinal flora. 

In this book we will focus on physicochemical profiling in support of improved prediction methods for absorption, the A in ADME. Metabolism and other components of ADME will be beyond the scope of this book. Furthermore, we will focus on properties related to passive absorption, and not directly consider active transport mechanisms. The most important physicochemical parameters associated with passive absorption are acid-base character (which determines the charge state of a molecule in a solution of a particular pH), lipophilicity (which determines distribution of a molecule between the aqueous and the lipid environments), solubility (which limits the concentration that a dosage form of a molecule can present to the solution and the rate at which the molecule dissolves from... 

Acetylcholine synthesis and neurotransmission requires normal functioning of two active transport mechanisms. Choline acetyltransferase (ChAT) is the enzyme responsible for ACh synthesis from the precursor molecules acetyl coenzyme A and choline. ChAT is the neurochemical phenotype used to define cholinergic neurons although ChAT is present in cell bodies, it is concentrated in cholinergic terminals. The ability of ChAT to produce ACh is critically dependent on an adequate level of choline. Cholinergic neurons possess a high-affinity choline uptake mechanism referred to as the choline transporter (ChT in Fig. 5.1). The choline transporter can be blocked by the molecule hemicholinium-3. Blockade of the choline transporter by hemicholinium-3 decreases ACh release,... 

Recently, Prasad et al. cloned a mammalian Na+-dependent multivitamin transporter (SMVT) from rat placenta [305], This transporter is very highly expressed in intestine and transports pantothenate, biotin, and lipoate [305, 306]. Additionally, it has been suggested that there are other specific transport systems for more water-soluble vitamins. Takanaga et al. [307] demonstrated that nicotinic acid is absorbed by two independent active transport mechanisms from small intestine one is a proton cotransporter and the other an anion antiporter. These nicotinic acid related transporters are capable of taking up monocarboxylic acid-like drugs such as valproic acid, salicylic acid, and penicillins [5], Also, more water-soluble transporters were discovered as Huang and Swann [308] reported the possible occurrence of high-affinity riboflavin transporter(s) on the microvillous membrane. 

Krupka, R. M., Uncoupled active transport mechanisms accounting for low selectivity in multidrug carriers P-glycoprotein and SMR antiporters,... 

Introduction Importance of Active Transport Mechanisms for Uptake,... 

Depending upon the mechanism that is employed by the organism to accumulate the solute, internalisation fluxes can vary both in direction and order of magnitude. The kinetics of passive transport will be examined in Section 6.1.1. Trace element internalisation via ion channels or carrier-mediated transport, subsequent to the specific binding of a solute to a transport site, will be addressed in Section 6.1.2. Finally, since several substances (e.g. Na+, Ca2+, Zn2+, some sugars and amino acids) can be concentrated in the cell against their electrochemical gradient (active transport systems), the kinetic implications of an active transport mechanism will be examined in Section 6.1.3. Further explanations of the mechanisms themselves can be obtained in Chapters 6 and 7 of this volume [24,245]. 

The nucleus is surrounded by the nuclear envelope, which takes on a lumenal structure connected to the endoplasmic reticulum. The transport of proteins into (and out of) the nucleus occurs through the nuclear pore complex (NPC), a large complex composed of more than 100 different proteins (Talcott and Moore, 1999). Because NPC forms an aqueous pore across the two membranes, small proteins less than 9 nm in diameter can pass through it simply by diffusion. However, most of the transports of both proteins and RNAs are mediated by an active transport mechanism. It is now clear that there is heavy traffic through the NPC in both directions. Proteins are not only imported into the nucleus but also actively exported from it as well. There are many reasons for nuclear export. One reason is to send some shuttle proteins back after their import another is for some viral proteins to export their replicated genomes outside the nucleus. 

Less direct evidence for active transport mechanisms includes the high degree of absorption of the P-gp substrate losartan in the isolated perfused rat lung, which indicated an absence of any absorption-retarding effect of P-gp [139], Evidence to the contrary includes an increase in the uptake of idaru-bicin when administered to the IPL via the perfusate in the presence of P-gp inhibitors [70],... 

Active Transport Mechanisms in Tracheo-Bronchial Epithelial Cells... 

Since active transport mechanisms require energy, the incubation temperature during the assay plays a crucial role. At 4°C, the fluidity of the cell membrane is reduced, the metabolism of the cell is downregulated, and energy-dependent transport processes are suppressed. Consequently, the amount of cell-associated target system refers mainly to the cytoadhesive fraction. In contrast, incubation at 37°C increases the fluidity of the cell membrane and the metabolic activity to an optimum, so both cytoadhesion and cytoinvasion occur at the same time. Thus, the uptake rate can be calculated from the difference in signal intensity measured upon incubation at both respective temperatures. 

---